A Clinical Study Comparing Symbicort 'as Needed' With Terbutaline 'as Needed' and With Pulmicort Twice Daily Plus Terbutaline 'as Needed' in Adult and Adolescent Patients With Asthma
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 04 Jul 2017
At a glance
- Drugs Budesonide/formoterol (Primary) ; Budesonide; Terbutaline
- Indications Asthma
- Focus Registrational; Therapeutic Use
- Acronyms SYGMA1
- Sponsors AstraZeneca
- 05 Jul 2016 Status changed from recruiting to active, no longer recruiting.
- 27 Apr 2016 Planned End Date changed from 1 Jun 2017 to 1 Aug 2017.
- 27 Apr 2016 Planned primary completion date changed from 1 Jun 2017 to 1 Aug 2017.